Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor.
Mankoff
D A
DA
Department of Radiology (Nuclear Medicine), University of Washington, Seattle 98195, USA.
Thompson
J A
JA
Gold
P
P
Eary
J F
JF
Guinee
D G
DG
Samlowski
W E
WE
D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging* / Q000556:secondary* / Q000628:therapy; D003847:Deoxyglucose / Q000031:analogs & derivatives*; D003951:Diagnostic Errors; D005260:Female; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D008875:Middle Aged; D018365:Neoplasm, Residual; D010386:Pelvic Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D011859:Radiography; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed
D005462:Fluorine Radioisotopes; D007376:Interleukin-2; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose